Who owns ACRIVON THERAPEUTICS INC?
- Ticker: ACRV
- CUSIP Number: 004890109
Tip: Access positions for across all investors
Analyze quarterly positions in Acrivon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acrivon Therapeutics stock
Who bought or sold ACRIVON THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 8.3M | $17M | 0% | Mar 2025 |
|
| Perceptive Advisors | 5.4M | $11M | 0% | Mar 2025 |
|
| Citadel Advisors | 1.9M | $3.8M | -11% | Mar 2025 |
|
| BlackRock | 939k | $1.9M | -1% | Mar 2025 |
|
| Wellington Management Company | 888k | $1.8M | 0% | Mar 2025 |
|
| Vanguard Group | 675k | $1.4M | 0% | Mar 2025 |
|
| Marshall Wace | 450k | $914k | -25% | Mar 2025 |
|
| Acorn Capital Advisors | 405k | $823k | 0% | Mar 2025 |
|
| Geode Capital Management | 306k | $622k | 2% | Mar 2025 |
|
| State Street Corporation | 233k | $472k | -2% | Mar 2025 |
|
| Charles Schwab Investment Management | 111k | $226k | -2% | Mar 2025 |
|
| Northern Trust | 109k | $221k | -7% | Mar 2025 |
|
| Bridgeway Capital Management | 78k | $158k | 4% | Mar 2025 |
|
| Goldman Sachs Group | 58k | $117k | -76% | Mar 2025 |
|
| Wealthedge Investment Advisors | 57k | $115k | 420% | Mar 2025 |
|
| Renaissance Technologies | 52k | $106k | 5% | Mar 2025 |
|
| Dimensional Fund Advisors | 44k | $90k | 19% | Mar 2025 |
|
| Invesco | 35k | $72k | 100% | Mar 2025 |
|
| Barclays | 33k | $66k | -14% | Mar 2025 |
|
| Bank of New York Mellon | 28k | $56k | 0% | Mar 2025 |
|
| Baker Bros. Advisors | 23k | $46k | -57% | Mar 2025 |
|
| American Century Companies | 17k | $35k | -1% | Mar 2025 |
|
| Rhumbline Advisers | 17k | $34k | -7% | Mar 2025 |
|
| UBS O'Connor | 16k | $32k | -85% | Mar 2025 |
|
| Susquehanna International | 15k | $30k | 100% | Mar 2025 |
|
| Nuveen | 13k | $27k | 100% | Mar 2025 |
|
| Springbok Capital Management | 13k | $27k | 100% | Mar 2025 |
|
| UBS Group | 13k | $26k | -9% | Mar 2025 |
|
| Citigroup | 11k | $23k | -10% | Mar 2025 |
|
| AAFCPAs Wealth Management | 11k | $22k | 0% | Mar 2025 |
|
| Intech Investment Management | 10k | $21k | 100% | Mar 2025 |
|
| Jpmorgan Chase & Co | 8.5k | $17k | -67% | Mar 2025 |
|
| Wells Fargo & Company | 7.1k | $14k | 2% | Mar 2025 |
|
| Mirae Asset Global Etfs Holdings | 7.1k | $14k | 5% | Mar 2025 |
|
| China Universal Asset Management | 6.2k | $13k | -5% | Mar 2025 |
|
| Corebridge Financial | 5.8k | $12k | -1% | Mar 2025 |
|
| Tower Research Capital | 3.1k | $6.3k | 75% | Mar 2025 |
|
| FMR | 2.7k | $5.4k | -9% | Mar 2025 |
|
| New York State Common Retirement Fund | 2.3k | $5.0k | 0% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.3k | $2.7k | -31% | Mar 2025 |
|
| Mirae Asset Global Investments | 1.0k | $2.3k | 0% | Mar 2025 |
|
| NISA Investment Advisors | 959.00 | $1.9k | 859% | Mar 2025 |
|
| California State Teachers Retirement System | 856.00 | $1.7k | 0% | Mar 2025 |
|
| Royal Bank of Canada | 849.00 | $0 | -48% | Mar 2025 |
|
| Legal & General Group | 839.00 | $1.7k | 0% | Mar 2025 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 800.00 | $1.6k | 0% | Mar 2025 |
|
| Gf Fund Management | 772.00 | $1.6k | 18% | Mar 2025 |
|
| Summit Investment Advisors | 695.00 | $1.4k | 0% | Mar 2025 |
|
| Deutsche Bank Aktiengesellschaft | 541.00 | $1.1k | 100% | Mar 2025 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $812.000000 | 0% | Mar 2025 |
|
| Amalgamated Bank | 378.00 | $999.999000 | 0% | Mar 2025 |
|
| Sterling Capital Management | 198.00 | $401.999400 | -51% | Mar 2025 |
|
| SBI Securities | 74.00 | $149.998000 | 0% | Mar 2025 |
|
| CWM | 49.00 | $0 | 20% | Mar 2025 |
|
| True Wealth Design | 3.00 | $6.999900 | 100% | Mar 2025 |
|
Who sold out of Acrivon Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DAFNA Capital Management | Dec 2024 | 112k | $677k |
| Exchange Traded Concepts | Mar 2025 | 23k | $47k |
| Trexquant Investment | Dec 2024 | 17k | $102k |
| Pale Fire Capital SE | Dec 2024 | 15k | $92k |
| Corton Capital | Dec 2024 | 12k | $73k |
| GAMMA Investing | Mar 2025 | 287.00 | $583.011800 |
| Russell Investments | Dec 2024 | 223.00 | $1.3k |
| Capital Advisors | Dec 2024 | 48.00 | $0 |